Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1900 of 5804
-
New prostate cancer radiotherapy aims to cut side effects
Symptom relief OngoingTrial design: A single centre phase II non-randomised study Trial population: Men with intermediate risk localised prostate cancer Recruitment target: 20 patients in total Trial objectives: * Primary To develop a 5 fraction de-escalated dose SBRT protocol capable of reducing …
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
AI brain scan tool could speed up stroke diagnosis
Diagnosis CompletedThis study evaluates Heuron CTA, a software that helps doctors detect blockages in brain blood vessels using CT angiography images. The software's results will be compared with diagnoses made by medical specialists to assess its accuracy. If it performs well, it may help doctors …
Sponsor: Heuron Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Could your phone diagnose sleep apnea? new study puts app to the test
Diagnosis CompletedThe goal of this clinical trial is to test the ability of the Apneal application in diagnosing sleep apnea in adult patients. Participants will be asked to wear the Apneal device during their fulll-night sleep test (polysomnography, the gold standard for sleep apnea)
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Diagnosis
Last updated Jun 26, 2026 19:03 UTC
-
New shot aims to tame high cholesterol and triglycerides
Disease control OngoingA Phase 2 in Patients With Mixed Dyslipidemia
Phase: PHASE2 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New MRI scan could replace painful liver biopsies for MASH patients
Diagnosis ENROLLING_BY_INVITATIONThe goal of this study is to assess the value of liver dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and texture analysis post gadopiclenol for liver fibrosis staging, in comparison with MR elastography, T1 mapping, ultrasound elastography and blood tests in 50 i…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Could a single pill transform heart failure care for underserved patients?
Disease control CompletedA novel four-drug regimen for heart failure with reduced ejection fraction (HFrEF) extends patients' life expectancy by an average of 6 years compared to traditional therapies, in addition to improving quality of life. Unfortunately, uptake of this complex multi-drug regimen has …
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New gel made from platelets shows promise for healing diabetic foot sores
Disease control CompletedThis is a Phase 2a Multi-Center, Prospective, Randomized, Controlled Study aimed to evaluate the Safety and Efficacy of Topically Applied PEP-TISSEEL in Subjects with Diabetic Foot Ulcers (DFU)
Phase: PHASE2 • Sponsor: Rion Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New heart device tested for long-term relief from AFib
Disease control Recruiting nowObservational, multi-center, non-randomized, post-market study. This is a nested sub-study of the REAL AF Registry. Consecutive symptomatic drug refractory paroxysmal atrial fibrillation (PAF) patients from the registry will be screened for enrollment, prospectively or retrospect…
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Generic fertility drug could cut IVF costs without sacrificing success
Disease control Recruiting nowThe goal of this clinical trial is to compare the clinical outcomes using different cetrorelix acetate in the context of a GnRH antagonist protocol for ovarian stimulation in women undergoing IVF or intracytoplasmic sperm injection(ICSI) treatment.The main question it aims to ans…
Phase: NA • Sponsor: Northwest Women's and Children's Hospital, Xi'an, Shaanxi • Aim: Disease control
Last updated Jun 26, 2026 19:11 UTC
-
New hope for patients with hard-to-treat pituitary tumors
Disease control Recruiting nowThe researchers are doing this study to find out whether pasireotide is an effective treatment for people with prolactinoma who cannot receive dopamine agonist therapy. Another purpose of this study is to find out whether pasireotide is a safe treatment for people with prolactino…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New DNA method may spot hidden joint infections faster
Diagnosis CompletedThe objectiveof this of a prospective, multicentre study is to evaluate the performance of shotgun metagenomics in the diagnosis of chronic Prosthetic joint infection (PJI) in comparison with the adapted MSIS diagnostic score.. The main questions it aims to answer are: * To eva…
Sponsor: University Hospital, Brest • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New app aims to tackle diabetes stress in School-Age children
Symptom relief OngoingThis R01 is in response to RFA-DK-19-021, Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes. The objective is to test the feasibility and acceptability of a novel, practical, and potentially scalable screen to treat program for diabetes distress in famili…
Phase: NA • Sponsor: Nemours Children's Clinic • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Heart clip aims to cut stroke risk in surgery patients
Disease control OngoingThe purpose of this study is to collect post-market clinical evidence on performance and clinical outcomes of the Penditure™ Left Atrial Appendage (LAA) Exclusion System in subjects undergoing concomitant cardiac surgery.
Phase: NA • Sponsor: Medtronic Cardiac Surgery • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a tailored dialysis schedule be safer for kidney patients?
Disease control Recruiting nowThis study is to prospectively compare clinical effectiveness between clinically- matched incremental hemodialysis and conventional hemodialysis in patients with incident kidney dysfunction requiring dialysis and residual kidney function. The study will enroll 350 patients on ch…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New balloon treatment may shorten blood thinner use for heart patients
Disease control OngoingPost-market, prospective, observational, multicenter, non-intervention study, to demonstrate the effectiveness of drug-coated ballon (DCB)therapy in real-world patients with small native vessel coronary artery disease, and to demonstrate the safety of short dual antiplatelet ther…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Spanish study checks Real-World use of MS drug ofatumumab
Disease control CompletedThis was a non-interventional, cross-sectional, multicentric, and nationwide study, based on primary and secondary data collection.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Brain surgery breakthrough? diaphragm zap may cut delirium risk
Disease control CompletedThis prospective, single-center, randomized controlled clinical trial aims to investigate the impact of intraoperative phrenic nerve stimulation (i.e., diaphragmatic neuromodulation) on postoperative complications in neurosurgical patients. The primary objective is to assess the …
Phase: NA • Sponsor: Beijing Sanbo Brain Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:13 UTC
-
New combo drug CagriSema shows promise in curbing appetite and food intake
Symptom relief CompletedThis research study tests if CagriSema influences food intake, appetite and emptying of the stomach in people with excess body weight. Participant will either get CagriSema (active medicine) or placebo (a dummy medicine), which has no effect on the body. The treatment participant…
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Spinal zaps may help failed back surgery patients walk again
Symptom relief Recruiting nowThe purpose of this study is to explore the changes in objective walking parameters induced by medullary stimulation in patients with Fail Back Surgery Syndrome, after chronic stimulation, in comparison with preoperative condition.
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New scan lights up hidden gut tumors
Diagnosis CompletedThis is a single-arm imaging study using DOTATOC peptide, labelled with the Gallium (68Ga) tracer.
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC